Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
11/2005
11/10/2005CA2564558A1 Process for the preparation of substituted tetralin and substituted indane derivatives
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1149066B1 Method of preparing alkylated salicylamides
11/09/2005CN1694865A Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005CA2141364C Polyisocyanate mixtures which are liquid at greater than 5° c
11/03/2005US20050245593 4-Aminomethyl-1-aryl-cyclohexylamine compounds
11/03/2005US20050245503 Therapeutic heterocycles
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590322A1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1159261B1 Antizyme modulators and their use
10/2005
10/27/2005US20050240049 Process for the preparation of substituted tetralin and substituted indane derivatives
10/27/2005US20050239879 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005CA2242177C Fluorocarbon-containing isocyanate derivatives and soil-resist agents
10/25/2005CA2059882C Sulfonylureas
10/20/2005WO2005097773A1 1,1’-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/20/2005WO2005097737A1 Method for producing polyether allophanates using zinc compounds as catalysts
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050233398 Lidocaine analogs and methods of making and using same
10/20/2005CA2560648A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/19/2005EP1586556A2 Compounds to treat Alzheimer's disease
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005CN1684682A Small organic molecules that increase the activity of gelatinase A in ocular cells
10/19/2005CN1683318A Synthetic method for 3, 5-dichloro-2, 4-difluoronitrobenzene and teflubenzuron
10/13/2005WO2005095333A1 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
10/13/2005WO2005058798A8 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same
10/13/2005US20050228062 Incorporable photoinitiator
10/13/2005US20050228033 Voltage-gated sodium channel (VGSC) and prostate voltage sodium channel (PVSC) inhibitors for treating diseases characterized by overabundant or hyperactive VGSC/PVSC's; phenytoin derivatives; use as sodium channel blockers, anti-cancer agents; can be used to limit or prevent PSA growth and metastasis
10/13/2005US20050228017 Novel anticancer compounds
10/13/2005DE10392134T5 Azaphenylalaninderivate Azaphenylalaninderivate
10/13/2005CA2560818A1 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
10/12/2005CN1680308A New 3-aryl-2-hydroxypropionic acid derivative I
10/12/2005CN1680302A Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative
10/12/2005CN1680301A Production of o-chlor-benzoylurea from tobacco stalks
10/11/2005US6953812 Carboxy and amide containing compound suitable for treatment and/or prevention of diseases wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, diabetes, disorders of the lipid metabolism, such as dyslipidemia
10/06/2005WO2005092843A1 Novel urea derivatives and their medical use
10/06/2005WO2005092841A1 Compounds having beta-agonist activity
10/06/2005US20050222365 Process for preparing polyether allophanates using zinc compound catalysts
10/06/2005CA2561639A1 Novel urea derivatives and their medical use
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005CA2094397C Homobifunctional agents for coupling enzymes and the like to antibodies and the like
09/2005
09/29/2005WO2005090288A1 Phenylaminoethanol derivates as beta2 receptor agonists
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005CA2559533A1 Phenylaminoethanol derivatives as beta2 receptor agonists
09/28/2005EP1242397B1 Trans olefinic glucokinase activators
09/28/2005CN1675176A Fluorinated urethane compounds and compositions containing the same
09/28/2005CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors
09/22/2005US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1577292A1 Phenylaminoethanol derivatives as beta2 receptor agonists
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575910A1 Developing constituents for dyeing keratin fibres
09/21/2005EP1575901A2 Substituted amides
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005CN1671654A Gelling agents
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/15/2005WO2005085180A1 Method of amidocarbonylation reaction
09/15/2005WO2005056520A8 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/14/2005EP1572632A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
09/14/2005EP1572629A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
09/14/2005EP1572625A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
09/14/2005CN1668582A Method for the continuous production of tetra-substituted ureas
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218935C Substituted benzoyl urea insect growth regulator synthesizing method
09/09/2005WO2005082862A2 Benzimidazolyl derivatives as kinase inhibitors
09/09/2005CA2557398A1 Benzimidazolyl derivatives as kinase inhibitors
09/07/2005EP1569897A1 Substituted tetralins and indanes
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665778A Hydroxy tetrahydro-naphthalenylurea derivatives
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/06/2005CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
09/01/2005US20050192442 reacting 2-hydroxy-6-aminocarbonyl naphthalene and an isocyanate in an organic solvent at a temperature of 90-200 degrees C.; high speed, high yields
09/01/2005US20050192347 Urea and thiourea compounds and compositions for cholesterol management and related uses
08/2005
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005CN1662575A Low-cure powder coatings and methods for using the same
08/31/2005CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma
08/31/2005CN1660795A Method for synthesizing sec-butyl urea
08/31/2005CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same
08/25/2005US20050187297 New compounds, methods for their preparation and use thereof
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/24/2005EP1565429A2 Aryl ureido derivatives and their medical use
08/24/2005EP1565428A1 Substituted ureas and carbamates
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/24/2005CN1659137A N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 99